Found 29 matching trials
1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD) PHASE3 This study was designed to investigate the 1 year efficacy and safety of th...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide. PHASE3 The study purpose is to evaluate the effect of QAB149
* NVA237 vs. QAB149 ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Long Term Safety Study of NVA237 vs QAB149 in COPD Patients PHASE3 The purpose of the study is to provide long term safety data of NVA237. Thi...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease PHASE3 This study will assess of the efficacy and safety of a once-daily, 50µg inh...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma PHASE2 The purpose of this trial is to characterize the bronchodilator effects and...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation PHASE3 This study will assess the efficacy, safety and tolerability of indacaterol...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
NVA237 BID Versus Placebo Twelve-week Efficacy Study PHASE3 The study serves to determine whether the treatment of patients with stable...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE4 The purpose of this study is to further figure out differences of glycopyrr...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease PHASE3 This study will assess the efficacy, tolerability and safety of NVA237 comp...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A Study to Investigate the Bronchodilatory Effect of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE2 This study was intended to assess how well inhaled NVA237 opens up the airw...
Show More Location
Spartanburg Medical Research
Learn More & Join Trial